Financials data is unavailable for this security.
View more
Year on year Kewaunee Scientific Corp had revenues fall -7.17% from 219.49m to 203.76m, though the company grew net income 2,441.06% from 738.00k to 18.75m.
Gross margin | 26.01% |
---|---|
Net profit margin | 9.28% |
Operating margin | 8.43% |
Return on assets | 14.62% |
---|---|
Return on equity | 38.70% |
Return on investment | 21.67% |
More ▼
Cash flow in USDView more
In 2024, Kewaunee Scientific Corp increased its cash reserves by 87.75%, or 12.12m. The company earned 19.56m from its operations for a Cash Flow Margin of 9.60%. In addition the company used 4.37m on investing activities and also paid 3.01m in financing cash flows.
Cash flow per share | 7.44 |
---|---|
Price/Cash flow per share | 4.92 |
Book value per share | 19.51 |
---|---|
Tangible book value per share | 19.51 |
More ▼
Balance sheet in USDView more
Current ratio | 2.53 |
---|---|
Quick ratio | 2.00 |
Total debt/total equity | 0.5698 |
---|---|
Total debt/total capital | 0.3569 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 2,409.89%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years) | 61.89 |
---|---|
EPS (TTM) vs TTM 1 year ago | 365.16 |